Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Change in Cash came in at $7.4 million in Q1 2026, up 2700.0% YoY from $263000.0 in Q1 2025, and up 166.94% on a QoQ basis from -$11.0 million in Q4 2025.
Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Change in Cash data on file, last reported at $7.4 million in Q1 2026.
- Quarterly Change in Cash rose 2700.0% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 128.62% YoY) and the FY2025 annual result came in at $8.2 million, up 389.62% from the prior year.
- Change in Cash improved to $7.4 million in Q1 2026, from -$11.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $50.8 million in Q1 2024 to a low of -$51.6 million in Q2 2024.
- A 5-year average of -$868176.5 and a median of -$5.2 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash plunged 703.51% — and 2026, when it soared 2700.0%.
- Tracing ACHV's Change in Cash over 5 years: stood at $6.6 million in 2022, then slumped by 166.52% to -$4.4 million in 2023, then jumped by 173.38% to $3.2 million in 2024, then plunged by 442.82% to -$11.0 million in 2025, then surged by 166.94% to $7.4 million in 2026.
- The last three Change in Cash figures came in at $7.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$19.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 19.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.88 Mn |
| Mar 31, 2026 | 7.36 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -19.94 Mn |
| Jun 30, 2025 | 38.86 Mn |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | -51.64 Mn |
| Mar 31, 2024 | 50.82 Mn |
| Dec 31, 2023 | -4.37 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Jun 30, 2023 | 8.56 Mn |
| Mar 31, 2023 | -8.26 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | -11.18 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.69 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | -8.69 Mn |